throbber
VOLUME 8, N0. 3, 2001
`
`ISSN 0793-0291
`
`PM
`
`Editor
`
`PROF. MARCEL GIELEN
`
`© 2001 FREUND PUBLISHING HOUSE LTI).
`
`Suite 500, Chesham House
`
`150 Regent Street
`London WIR SFA
`
`England
`
`CFAD V. Anacor, |PR2015-01776 ANACOR EX. 2136 - 1/9
`
`CFAD v. Anacor, IPR2015-01776 ANACOR EX. 2136 - 1/9
`
`

`
`No part of this publication may be reproduced, stored in a retrieval system or transmitted in any
`form or by any means, electronic or otherwise, without permission in writing from the publisher
`
`Published monthly by Freund Publishing House Ltd. 2001 Subscription Price: $350.-
`Orders should be addressed to: Subscriptions Department, Freund Publishing House Ltd,
`Suite 500, Chesham House, 150 Regent Street, London WIR SFA, England or P.O.Box 35010,
`Tel Aviv, Israel
`
`COPYRIGHT © 2001
`BY FREUND PUBLISHING HOUSE LTD.
`
`CFAD V. Anacor, |PR201 5-01 776 ANACOR EX. 2136 - 2/9
`
`CFAD v. Anacor, IPR2015-01776 ANACOR EX. 2136 - 2/9
`
`

`
`METAL-
`
`BASED
`
`DRUGS
`
`Tl
`1’ Km 4”‘;
`
`/7
`
`-1
`
`-
`
`\
`
`,:\
`
`\ F,
`
`l
`M
`
`2 , _,_\ Q
`_/J‘\ /2\ ‘,/”“\
`l_,. \.
`a ti cl pi e /2 wi mi
`
`Metal-Based Drugs, 8 (2001), 119 - 124
`
`ACTIVITY OF Pt(||) AND Flu(I|I TFIIAZOLOPYFIIMIDINE COMPLEXES AGAINST
`PARASITES OF THE 6 /VUS LE/SHMA/V/A, 7'/-?I’PA/VOSOMASAND
`PHI’7'0/I/I0/VAS
`
`Juan M. Salas*,‘ Miguel Quiros,‘ Mohammad Abul Haj,‘ Rosa Magan,2
`Clotilde Mari’n,9 Manuel Sa'nchez—Moreno2 and Rene’ Faurea
`
`"2 Universidad de Granada. 18071 Granada, Spain
`3 Université Claude Bernard Lyon 1, 69622 Villeurbanne, France
`
`The synthesis and characterization of two Pt II) complexes with the can
`isom_er_ic
`li ands 4,5-dih d.ro-5-oxo- 1 2,4] ria_zolo—[1,5-
`alpyrimidine %?HtpO) and 4, -dihydro-7-oxo-I1,2,4]-triazolo-[1,5- ,,
`
`apyrimidine HtpO) are described, as well as a Ru(l|l) comp|ex,,,=v
`with 7HtpO. he crystal structure of ci_s-[PtCl (7HtpO)2].2H O has
`been solved by X-ray diffraction analysis. In vifro activity oft e new
`isolated complexes against the epimastigote form of T. cruzi,
`procyclic form ofT. b. brucei and promastr ote form of L. donnovani
`and P. characias has also been studie . The three complexes
`markedly affect the growth of the parasites and none of them shows
`cytotoxicity against macrophage of the J774.2 line at the heaviest
`dosaes use .
`
`Metal-Based Drus, 8 2001 , 125 - 136
`INTERACTION OF RUTHEN|UM(II)-DIPYRIDOPHENAZINE COMPLEXES WITH
`CT-DNA: EFFECTS OF THE POLYTHIOETHER ANCILLARY LIGANDS
`Teresa M. Santos“, Joao Madureirat, Brian J. Goodfellowt, Michael G. B. Drewz,
`Julio Pedrosa de Jesus‘, and Vitor Felix‘
`‘Department of Chemistry, University of Aveiro.
`Campus Universitario de Santiago, 3810-1 93 Aveiro, Portu al, te_resa@dq.ua6)t
`2Department of Chemistry, The University. Whiteknights,
`eading, RG6 6A , UK
`
`2 ([9]aneS,=1,4,7-
`1 and [[Fiu(é12]aneS4)(dppz) Cl
`The complexes [Ftu([9 aneS§)(dppz C|]Cl
`trithiaciclononane and 1
`ane 4=1,4,
`,10-tetrathiacic odo ecane) were synt esised and fu||y'char_ac-
`tensed. These complexes elong to a small family of dipyridofihenazine complexes with non-polypyridyl
`ancillary ligands. Interaction studies of these complexes wit CT-DNA (lJV/Vis titrations, steady-state
`emission and thermal denaturation) revealed their high affinit
`for DNA.
`Intercalation constants
`determinedbyUV/Vistitrationsareofthesameorderofma nitude(1 6)_asotherdppzmetallointercalators,
`namely [Ru(l )(bpy)2dppz 2*. Differences between 1 and were identified by steady—state emission and
`thermal denaturation stu ies. Emission results are in accordance with structural data, which indicate no
`geometric distortions and different donor and/or acceptor ligand abilities affect luminescence. The
`possibility of non—covalent interactions between ancillary ligands and nucleobases by van der Waals
`contacts and H-bridges is discussed. Furthermore,‘ complex 1 under oes a uation under intra—cellula
`conditions and _an equilibrium with the aquated form 1' is attained.
`his be aviour may increase the
`diversity of available interaction modes.
`
`CFAD V. Anacor, |PR20’|5-01776 ANACOR EX. 2136 - 3/9
`
`CFAD v. Anacor, IPR2015-01776 ANACOR EX. 2136 - 3/9
`
`

`
`, 137 - 143
`I Metl-Based Dru
`TRANSITION METAL ION COMPLEXES OF SCHIFF-BASES.
`
`SYNTHESIS, CHARACTERIZATION AND ANTIBACTERIAL PROPERTIES
`Zahid H. Chohan“, Asifa Munawal and Claudiu T. Supurang
`_
`1 Department of Chemistry, lslamia University, _Bah_awalpur, Pakistan
`2 Universita degli Studi, Dipartimento di C imica, Laboratorio di Chimica lnorganica e Bioinorganica,
`Via Gino Capponi 7, I-50121 Florence, Italy
`Some novel transition metal Co(ll), Cu(ll% Ni(ll) and Zn(ll)] com-
`pkexes of subdsgtutald payritldine
`chiflfibajses lave lluajen prfipared and
`c aracterize
`yp sica,s ectra an ana tica
`ata.
`es nt e-
`sized Schitf—bases/ act as deprotonate/d tridentate foyr
`the
`complexation reaction with Co(l|),
`'(II) and Zn(|l) ions. The new
`corn ounds. possessing the
`eneral formula 2[M(Lg2] wher4e
`[M= o(ll), Cu( ), Ni(Il) and Zn(ll and HL=HL , HL , HL and HLI
`show an octrahledral graoréiefilryflln ordertg ehvaluate tae effefit of ngeta
`ions uponc e ation,t e c I
`asesan t eircom exes ave een
`sgregnedhior ar/i_tibEi‘cte;i7a|/ activity against thejstaraainsdsuch as
`
`seu omonas
`fap yocaccus aureus, an
`so er/0 /a 00/,
`aeruginosa. The complexed Schiff bases have shown to be more
`antibacterial a ainst one more bacterial species as compared to
`uncomplexed chit—bases.
`
`Metal-Based Drugs, 8 (2001), 145 - 148
`NEW BORON ANALOGUES OF PYROPHOSPHATES AND
`DEOXYNUCLEOSIDE BORANOPHOSPHATES
`Kamesh Vyakaranaml, Geeta Rana‘, Nara an S. Hosmane“,
`and Bernard F. Spielvogel "2
`‘ Department of Chemistry and Biochemistgyé Northern Illinois University,
`DeKalb, IL 60115-28
`USA
`2 Metallo-Biotech International, |nc., 663 Teal Court, DeKalb, IL 60115-6201, USA
`
`Tetraethyldicyanoborane
`pyrophosphate
`(2)
`and
`3’-
`(diethylphosphite-cyanoborano)-5’-
`dimethoxytrityl-N4—benzoyl-
`deoxycytidine (3) have been
`0
`OH
`OH
`synthesized in 70% and 76% yields,
`I
`|
`I
`respectively. The compatibility ofthe
`substituted boranophosphates with EtO""P'—O:P:OET NCH2 B‘_P"'OEt
`common protecting groups is
`l
`l
`hereby demonstrated.
`BHZCN
`GET
`
`DM-l-_
`
`H
`
`BHZCN
`
`Metal-Based Drus, 8 2001 , 149 - 158
`
`ANTIANDROGEN AND ANTIMICROBIAL ASPECTS OF COORDINATION
`COMPOUNDS OF PALLAD|UM(lI), PLAT|NUM(I|) AND LEAD(||)
`R.V. Singh“, SC. Joshiz, Shalini Kulshrestha‘, Pooja Nagpal‘ and Anil Bansal‘
`‘Department of Chemistry, 2Department of Zoology, University of Rajasthan, Jaipur—302004, India
`The complexes M(MaL”l(R )]Cl, and [Pb(l\[laL")(Ra)X MM = Pd" or Pt“ and X : Cl or NO have been
`synthesized b ‘the reac ioris ormacrocyclic ligan s E
`aL”) with metal salts and ditferen diamines in
`1:1 :1 molar ra IO in methanol. The complexes were characterized b elemental anal ses m olecular
`wei htdeterminations,conductivity measurements, IR, ‘H NMR,‘3C MR, ‘95PtNMR,
`‘7PbNMR,XRD
`an electronic spectral studies.
`The macrocyclic ligand coordinates through thefourazomethine
`R2
`nitrogen atoms which are brid ed by benzil moieties. IR spectra
`su gest that
`the pyridine ni rogen is not coordinatin . The
`a adium and
`latinum com lexes exhibit
`tetracoor inated
`gquareplanarlggometry, wherpeas a hexacoordinated octahe—
`dral geometry IS sug ested forlead com lexes. The complexes
`havebeen evaluate for their antimicro ial effects on di ferent
`species of pathogenic fungi and bacteria. The testicular sperm
`density, testicular sperm morphologjy aperm motiIi_ty, density of
`cauda epididymal spermatozoa an te ility in mating trails and
`biochemical _arameters of reproductive organs have been ex-
`amined and iscussed.
`
`X
`N
`N
`/ \ / \
`
`CeH5
`
`H5c6
`
`CFAD V. Anacor, |PR20’|5-01776 ANACOR EX. 2136 - 4/9
`
`CFAD v. Anacor, IPR2015-01776 ANACOR EX. 2136 - 4/9
`
`

`
`Metal-Based Drus, 7 2000 , 159 - 164
`CHARACTERIZATION AND ANTIMICROBIAL ACTIVITY OF
`ERBIUM(I||) COMPLEXES
`S. B. Jagtap‘, N. N.Patil*2,B. P.Kapadnis*9 and B. A. Kulkarni‘
`University of Pune, Pune - 411 007. lndia ‘Department of Chemistry 2Department of Microbiology
`<bpkap@unipune.ernet.in>
`of 2-hydroxy—1,4-naphthoquinone~1-
`Erbium(lll) metal complexes
`oxime and their C-3 substituted derivatives were synthesized. The
`complexes were characterized by melting point, elemental analysis, IR
`and ‘HNMR spectroscopy and magnetic susceptibility. The antimicro—
`bial activity of these complexes was determined by well diffusion
`method against the target microorganisms, Sfap/7y/ococcus aureus,
`/Ya/71‘/70/770/7as campesfr/19, Pseudomonas aerug//703a, Ca/70’/'0’a
`a/b/ca/vsand Asperg///L/5/7/gen The antimicrobial activity of ligands and
`their complexes was compared. it was seen that the ligands are more
`antifungal than antibacterial and the antimicrobial activity of the ligands
`reduced on complexation with erbium(lll).
`
`HO
`\
`
`N
`J
`
`Er)3
`\
`O
`
`Metal-Based Drugs, 7 (2000), 165 - 169
`SSYNTHESIS, CHARACTERIZATION AND IN VITRO ANTIFUNGAL EF-
`FECT OF SOME BUTYLTIN(IV) N-SUBSTITUTED 2-AMINOETHANETHIOLATES
`A. Smicka‘, V. Buchtag and K. Handlir*‘
`1 Department of General and Inorganic Chemistrg, Faculty of Chemical Technology, University of
`Pardubice, nam. Cs. Legii 565, 5 2 10 Pardubice, Czech Republic
`<ales.smicka@upce.cz>, <karel.handlir@u8ce.cz>
`_
`_
`9 Department of Biolo ical and Medical Sciences, Faculty of
`harmacy, Charles_University,
`Heyrovskeho 12 3, 500 05 Hradec Kralove, Czech Republic <buchta@faf.cuni.cz>
`Six new N—substituted di- and tributyltin
`cysteaminates 2—amino_ethanthiolates have been
`ltl‘iEaa;‘E‘éa1?§sEoS’aiifi'£F;§Seb3oH?‘Sinai’? $2
`.
`X
`considerable //7 i//1)‘/r0 fungicidal ac ivity against se—
`lected types of fungi (Ca/70’/‘c/a a/b/Ca/75, Cano’/'0’a
`/rrc,/5e/, Ca/70’/da
`rap ‘ca//5, Ca/70’/'0’a g/abrafa,
`7'r/0/,70,s,00r0/7 be/ge///; Asperg///us /um/galus,
`/4175/0’/a
`/)
`c0r+/r/177b//‘era,
`7'r/'0/lg /7}/[fin
`me/7/.3 rap res.
`is activit
`is com ara etot e
`commgnly u}s/,ed)drugs. The IIelationIs3hip between
`structure and fun icidal activit
`is discussed.
`
`11
`1
`2 n
`1 D
`‘
`
`=3;X:-CH2-
`;3;X=_o-
`
`=3;X -'— -NCH3
`
`/
`\
`/\,N X
`BU”Sn S U
`
`Metal-Based Dru s, 7
`
`COPPER(|I) ACYLHYDRAZINATES.
`THEIR SYNTHESIS AND CHARACTERIZATION
`Zahid H. Chohan*I, M. A. Farooq‘ and Claudiu T. Supurang
`.
`‘Department of Chemistry, lslamia Universit
`, Bahawalpur, Pakistan
`Laboratorio di Chimica lnorganica e Bioinorganica,
`niversita degii Studi, Via Gino Capponi
`7, I-50121, Firenze, Italy
`
`2
`
`Acylhydrazine derived furan I and thienyl
`Sc iff bases and their Cu(l) complexes
`have been pre ared and characterized on
`the basis of t eir physical, spectral and
`analytical data. The preferred enolic form
`of the Schiff base function as a tetradentate
`ligand during coordination to the metal ion
`gelding a square planar complex. The
`chiff bases and their complexes with dif-
`ferent anions were tested for their antibac-
`terialactivitya ainstbacterials ecies such
`as Est:/7er/c /a co//; S/ap 7}//ococcus
`aurez/5, Pseudomonas aerug//705a a‘/70’
`/(/abs/e//a pneu/770/7ae..
`
`CFAD V. Anacor, |PR2015-01776 ANACOR EX. 2136 - 5/9
`
`CFAD v. Anacor, IPR2015-01776 ANACOR EX. 2136 - 5/9
`
`

`
`Ajeful Based’ D]~l(gs
`
`This material may be protected by Copyright law (Title 17 U.S. Code)
`
`I/0/g 8‘ /’\/r. 3, I
`
`NEW BORON ANALOGUES OF PYROPHOSPHATES AND
`DEOXYNUCLEOSIDE BORANOPHOSPHATES
`
`~
`Kamesh Vyakaranam‘, Geeta Ranal. Narayan S. Hosmane*1, and Bernard F. Spie1Vogel*
`
`1.2
`
`' Depaitmept of Chemistry and Biochemistry, Northern Illinois University, DeKa1b, 1L 601 15-2862, USA.
`‘ Metallo-Biotech International, 1iic.. 663 Teal Court, DeKalb, IL 60115-6201, USA
`
`ABSTRACT
`
`Tetraethyldicyanoborane pyrophosphate (2) and 3‘-(diethylphosphite—cyanoborano)-5’-dimethoxytrityl-N‘-
`benzoyl-deoxycytidine (3) have been synthesized in 70% and 76% yields, respectively. The compatibility of
`the substituted boranophosphates with common protecting groups is hereby demonstrated.
`
`Boron containing biologically active compounds. such as nucleosides and nucleotides "6 and amino acids M
`are important due to their potential therapeutic activity, research and diaonostic applications. Many boron
`containing compounds have shown promising activity as anticancer,“ H‘
`'3 antiinflammatory,]3 and
`antiosteoporotic “agents. Oligonucleotides in which a non-bridging oxygen atom is replaced by a borane
`(BH3) group are a very important class ofmoditied nucleic acids. 1‘
`3‘ “"6 The BH3 group is isoelectronic with
`oxygen in natural oligonucleotides and isoelectronic and isostructural with the oligonucleotide methyl
`phosphonates, which are nuclease resistant. On the other hand,
`the ot—borano triphosphates are good
`substrates for DNA polymerases and inpor oration of boranophosphates into DNA causes an increase in the
`resistance to exo— and endonucleases " I
`“ as compared to non—modified DNA. There are also notable
`.
`.
`s
`.
`.
`,
`.
`7
`.
`.
`.
`7
`applications ot the ot-borano triphosphates in PLR sequencing ' 3 and nucleic acid detection] b
`
`Figure 1. Isoelectronic Nucleic Acid Backbones
`
`ii
`
`Boranophosphate
`
`Methylphosphonate
`
`Although considerable effort and progress has been made with the boranophosphate linkage,
`numerous limitations with this moiety still exist, especially in chemical syntheses. Thus, the highly reducing
`borane group causes base degradation and incompatibility with commonly used protecting groups in
`modified oligonucleotide synthesis.3‘“)‘ '8“ Likewise, the BH3 moiety has severe toxicity implications.
`' We
`have been intensively investigating the attachment of substituted boranes such as BH3X, where X : COOR,
`C(O)NR’H, CN, etc.,
`to phosphorus in biologically important molecules. Here we report the use of
`substituted boranes in the syntheses ofboronated pyrophosphates and nucleic acids which promises to greatly
`expand the scope ofthis class ofnucleic acids.
`Reaction of the potassium saltzo of diethylphosphite-cyanoborane 1 with methanesulfonyl chloride
`gave tetraethyldicyanoborane pyrophosphate 2 as shown in Scheme 1. Purification was achieved by column
`chromatography using ethyl acetate as an eluent. The yields range from 65-71% 31. Analysis by “P NMR
`spectroscopy showed a quartet of triplet at 5 80.21 ppm corresponding to the cyanoborane phosphate group.
`The "B NMR spectrum of2 contained a doublet of triplet at 5 — 40.58 ppm corresponding to cyanoborane
`phosphate group. [R spectrum of the purified product showed a broad band at 2409 cm‘ corresponding to B-
`H stretch and a sharp peak at 2361 cm" consistent with CN stretch.
`
`CFAD V. Anacor, |PR20’|5-01776 ANACOR EX. 2136 - 6/9
`
`145
`
`CFAD v. Anacor, IPR2015-01776 ANACOR EX. 2136 - 6/9
`
`

`
`Narayan S. Hosmane er al.
`
`New Boron Analogues of Pyrop/iosp/tales and
`De0xy11z1c/eoside B0/'an0p/705p/rates
`
`REACTION SCHEME 1:
`
`Brz /DME
`
`(OEUSP
`
`Nai3H;,CN——> (BH2C-\l)x"DI:’
`
`Eto-——[>———oEt
`
`BH2X
`
`Et
`
`pEt
`pEt
`plat
`MeSO3Cl
`Eto—- —oK —-——> Eto—-—— —-o--P-oEt
`F
`CH3CN
`BHZX
`
`BHZX
`
`BHZX
`
`1 X=CN
`
`2 X=CN
`
`REACTION SCHEME 2:
`
`C/Bz
`
`.
`(l)t-BuL1 THF
`——e——->—
`(2) 2 /riir
`(3) Water
`
`H
`
`p
`XHZB--P--C)Et
`
`(4) Column chromatography
`
`OE‘
`
`The preparation of K’ (RO)3PBH;,' salt and analogous tetramethyl-boranopyrophosphate was previously
`reported by [mamato ez. al. 22, and demonstrated to have good versatility in the preparation of
`boranophosphate compounds. However, these species may still be of limited use because of the presence of
`highly reducing BH3 moiety. Convincing evidence that sziibstitmed boranes with less reducing power can
`mitigate many of the problems caused by the BH3 group is demonstrated by the synthesis of 3.
`In this
`instance, the 5’-trityl protected group is retained in the synthesis whereas with borane unit, BH3,
`it
`is
`completely removed. 3"“ Thus, the reaction of5’—protected 2’-deoxycytidine, Benzoyl (B2), dimethoxytrityl
`(DMT) deoxycytidine, with pyrophosphate 2 (Scheme 2), followed by evaporation ofthe solvent resulted in
`the formation of 3’-(diethylphosphite-cyanoborano)- 5’-dimethoxytrityl-N4-benzoyI-deoxycytidine 3. This
`crude product was purified by flash chromatography and obtained in 75% yield (by ‘H NMR) 23. Analysis by
`“P NMR spectroscopy showed a quartet of triplet at 5 68.12 ppm corresponding to the cyanoborane
`
`146
`
`CFAD V. Anacor, |PR20’|5-01776 ANACOR EX. 2136 - 7/9
`
`CFAD v. Anacor, IPR2015-01776 ANACOR EX. 2136 - 7/9
`
`

`
`Metal Based Drugs
`
`V0], 8, N;-, 3, 2001
`
`phosphate group. The “B NMR spectrum of2 contained a doublet oftriplet at 5 —~ 39.63 ppm corresponding
`to cyanoborane phosphate group. IR spectrum of the purified product showed two broad bands at 2762 and
`2701 cm'], corresponding to B-H stretch, and a sharp peak at 2295 cm" is consistent with CN stretch. The
`DMT protecting group and boranophosphate were incompatible in previous synthetic proeedL11‘es.3“"8
`However, with the use of the less reducing cyanoborane, the DMT nucleoside was isolated in 75% yield
`using the procedure described here. Substituted boranes are less reducing than BH3 moiety and should also
`inhibit the base degradation. In fact, cyanoborane adducts of various N positions of purine and pyrimidine
`nucleosides have been prepared with the bases not reduced or degraded. M’)
`Thus, in View ofthe great importance of phosphate moieties (pyrophosphates. nucleic acids, etc.) in
`biological processes,
`the availability of boronated phosphates, such as 2 and 3,
`is expected to be of
`considerable interest. Work on a variety of such species is currently underway in our laboratories.
`
`ACKNOWLEDGMENT. This work was supported by grants from the National Science Foundation (CHE-
`9988045), the donors ofthe Petroleum Research Fund, administered by the American Chemical Society, and
`Northern Illinois University through Presidential Research Professorship (to NSH).
`
`REFERENCES
`
`* Corresponding author, Fax (815)753-4802, email: nhosmaneiYTIniu.edu
`l. Hasan, A.; Li, H.; Tomasz, 1.; Shaw, B.R.; Nucl. Ac1'a’Res. 1996, 2-/, 2150-2157.
`2.
`(a) Li, H.; Porter, K.; Huang, F.; Shaw, B.R.; Nucl. Acid Res. 1995, 23, 4495-4501. (b) Sood, A.;
`Shaw, B.R.; Spielvogel, B.F.; J. Am. Chem. Soc. 1990, 112, 9000-9001. (C) Sood, A.; Spielvogel.
`B.F.; Shaw, B.R.; J. Am. Chem. Soc. 1989, II], 9234-9235.
`Spielvogel, B.F.; Sood, A.; Shaw, B.R.; Hall, I.H.; Fairchild, R. G.; Laster, B.H.;
`Progress in Neutron Capture therapy for Cancer 1992, 21 1-213.
`Shaw; B.R.; Madison, 1.; Sood, A.; Spielvogel, B.F.; Methods in Mol. Biol. 1993,20, 225-243.
`Kane, R.R.; Drechsel, K.; Hawthorne, M.F.; J. Am. Chem. Soc. 1993, /15, 8853-8854.
`Spielvogel, B.F.; Sood, A.; Shaw, B.R.; Hall, I.H.; Pure Appl. Chem. 1991, 63. 415-418.
`Spielvogel, B.F.; Sood, A.; Tomasz, 1.; Shaw, B.R.; Karthikeyan, S.; Neutron Capture The/'. 1993,
`361-365.
`
`Gordon, C.;
`
`Kane, R. R.; Pack, R. H.; Hawthorne, M.F.; J. Org. Chem. 1993. 58, 991-992.
`Hall, I.H.; Hall, E. S.; Chi, L.; Shaw.B. R.; Sood, A.; Spielvogel, B. F.; Anticancer Res. 1992, 12,
`1091-1098;
`. Sood, A.; Spielvogel, B.F.; Shaw B.R.; Carlton, L.D.; Burnham, B.S.; Hall, E.S. Hall. I.H.; ibid.
`1992, 12, 335-334.
`.
`. Sood, A.; Shaw, B.R.; Spielvogel, B.F.; Hall, E.S.; Chi, L.K.; and hall, I.H.;
`833-838.
`
`Pharmazie 1992, -/7,
`
`. Spielvogel, B.F.; Sood, A.; Shaw, B.R.; Hall, I.H.; Curr. Top. Chem. Boron Proc. Int. Meet. Boron
`Chem, 3"‘, 1994, pp. 193-193.
`. Rajendran, K.G.; Burnham, B.S.; Chen, S.Y.; Sood, A.; Spielvogel, B. F.; Shaw, B.R.; Hall. I.H. J.
`Pharm. Sci. 1994, 83, 1391-1395.
`Tomasz, 1.; Shaw. B.R.; Porter, K.W.; Spielvogel, B.F.; Sood, A. Angew. Chem, Int. Ed. Engl.
`1992, 31,1373—1375.
`. Krzyzanowska, B. K.; He, K.; Hasan, A.; Shaw, B.R. T.<:tral7edron 1998, 54. 5119-5128.
`. He, K.; Hasan, A.; Krzyanowska, B. K.; Shaw, B.R. J. ()1 g. Chem. 1998, 63. 5769-5773.
`.
`(a) Porter, K. W.; Briley, 1.D.; Shaw, B.R.; Nucleic Acid Res. 1997, 25, 1611-1617. (b) Spielvogel,
`B. F.; Powell, W.; Sood, A. Main Group Metal Chemistry, 1996, [9, 699-704.
`(a) Higson, A. P.; Sierzchala, A.; Brummel, H.; Zhao, Z.; Caruthers, M. H. Tetrahedron Letters,
`1998, 39, 3899-3902. (b) Levinskas, G. 1., Boron, Metalloboron compounds and Boranes, Chap. 8,
`lnterscierzce, 1964.
`(a) Eriksson, B.; Oberg, B.; Wahren, B. Biochim. Biophys. Acta 1982, 696, 115-123. (b) Eriksson,
`B.; Larsson, A.; Helgstrand, E.; Johansson, N. (1.; Oberg, B. Biochim. Biophys. Acta 1980, 607, 53-
`64. (c) Eriksson, B.; Tao, P. Z.; Wahren, B.; Oberg. B. Proc. Int. Confr. Chemothe/2; 13th, 1983, 6,
`1 14/'29-1 14/32.
`
`.
`
`.
`
`. Sood, A.; Sood, C.K.; Hall, I.H.; Spielvogel, B.F. Tetrahedron, 1991, 47, 6915-6930.
`potassium salt of
`. Methanesulfonyl chloride (0.96g, 8.34mrnol) was added to a solution of the
`diethylphosphite-cyanoborane (3.0g, 13.9mmol) in acetonitrile (50 mL) at 00C and the mixture was
`stirred at room temperature for 4 h. The precipitated solid was removed by filtration, and the filtrate
`was concentrated under reduced pressure. The residual oil was passed through a short column of
`silica gel with ethyl acetate to give 3.25g (70%) compound 2 as a colorless oil.
`'H NMR (200 MHZ;
`DMSO reference to TMS) 5 1.20 (sh, t, 3H), 3.35 (sh "tn, 2H); “B NMR (54.21 MHZ; DMSO
`reference to BF3.OEt2)5 -40.58 ((1 oft, 1./B,» 1 160.4 Hz); i’C NMR (50.32 MHz; DMSO reference to
`TMS) 8 16.9 (d of d, ’Jpc = 4.0 Hz, C113; 57.71, d ofd, 2.11%; = 4.9112, CH3). "P NMR (81.01 MHZ;
`
`147
`CFAD V. Anacor, |PR2015-01776 ANACOR EX. 2136 - 8/9
`
`CFAD v. Anacor, IPR2015-01776 ANACOR EX. 2136 - 8/9
`
`

`
`Nara an S. Hosmane et a/.
`J’
`
`New Boron Ana/0 1/es 0 P 11:0 7/ms hates and
`8’
`.
`J
`I
`/7
`Deoxyrzztc/e0s1‘de Boranophasp/zates
`
`.
`
`DMSO reference to H3PO4) 5 80.21 (q of t, Jpg = 163 Hz);1R(KBr pellet) 2409, 2361 v(Bl'l); 2209
`v(CN). Anal. Calcd for CmH;4P3O3B3N3: C, 35.74; H. 7.2; N, 8.33. Found: C, 35.01; H, 7.9; N,
`8.56. This compound decomposes at 120 °C.
`_
`lmamoto. T.; 1.; Nagato, E.; Wada, Y.; Masuda. H.; Yamaguchi, K.; Uchimaru, T. J. Am. Chem.
`Soc. 1997, /19, 9925-9926.
`. Benzoyl-Dimethoxytrity1-deoxycytidine (250 mg, O.4mmol) was dissolved in 15 mL ofTHF and the
`solution was cooled to -78 0C. After 30 minutes, t—BuLi (1.0mL, 1.25mmol) was added to the
`reaction mixture and the reaction was carried out for 30 minutes. Tetraethyldicyanoborane
`pyrophosphate (200mg, O.5m1nol) dissolved in 10mL of THF was added to the solution and reaction
`continued for 18 h. The solvent was evaporated under reduced pressure. To the crude extract, 25 mL
`of water was added and solution was stirred for 5 h. The solid was filtered off and purified by
`chromatography using ethyl acetate/' hexane (9:1) to give O.24g (75.7%) ofcompound 3. ‘ll NMR
`(200 MHZ; DMSO reference to TMS) 5 8.23 (m, 5H, Ar—H), 7.69(br. 13H. Ar-H), 7.65 (cl, 2H. H-5,
`H-6), 6.18 (t, 1H, H-1’), 2.21, 2.15 (m, 2H. H-2’), 4.0 (m. 1H. H-3’), 5.37 (m, 1H, H-4’), 3.67, 4.05
`(m, 2H. H-5’). 3.95 (q, 4H), 1.3fl(t, 6H); “B NMR (64.21 MHz. DMSO reference to BF_~..OEt3) 5 —
`39.63 (d oft, ‘.15.. = 178.6 Hz ); ~‘ P NMR (81.10 MHZ; DMSO reference to H;.Po.) 5 68.12 (q of 1,
`Jpg = l63Hz). IR (KBr pellet) 2762, 2701 \/(BH); 2295 V(CN). Anal. Calcd for C.;3l'l4(,O9N4BP: C.
`63.63; H. 5.80; N, 7.07. Found: C, 62.89; 1-1, 6.10; N. 6.42.
`
`Received: May 28, 2001 —- Accepted: June 20, 2001 —
`Accepted in publishable format: June 20, 2001
`
`CFAD V. Anacor, |PR201 5-01 776 ANACOR EX. 2136 - 9/9
`
`CFAD v. Anacor, IPR2015-01776 ANACOR EX. 2136 - 9/9

This document is available on Docket Alarm but you must sign up to view it.


Or .

Accessing this document will incur an additional charge of $.

After purchase, you can access this document again without charge.

Accept $ Charge
throbber

Still Working On It

This document is taking longer than usual to download. This can happen if we need to contact the court directly to obtain the document and their servers are running slowly.

Give it another minute or two to complete, and then try the refresh button.

throbber

A few More Minutes ... Still Working

It can take up to 5 minutes for us to download a document if the court servers are running slowly.

Thank you for your continued patience.

This document could not be displayed.

We could not find this document within its docket. Please go back to the docket page and check the link. If that does not work, go back to the docket and refresh it to pull the newest information.

Your account does not support viewing this document.

You need a Paid Account to view this document. Click here to change your account type.

Your account does not support viewing this document.

Set your membership status to view this document.

With a Docket Alarm membership, you'll get a whole lot more, including:

  • Up-to-date information for this case.
  • Email alerts whenever there is an update.
  • Full text search for other cases.
  • Get email alerts whenever a new case matches your search.

Become a Member

One Moment Please

The filing “” is large (MB) and is being downloaded.

Please refresh this page in a few minutes to see if the filing has been downloaded. The filing will also be emailed to you when the download completes.

Your document is on its way!

If you do not receive the document in five minutes, contact support at support@docketalarm.com.

Sealed Document

We are unable to display this document, it may be under a court ordered seal.

If you have proper credentials to access the file, you may proceed directly to the court's system using your government issued username and password.


Access Government Site

We are redirecting you
to a mobile optimized page.





Document Unreadable or Corrupt

Refresh this Document
Go to the Docket

We are unable to display this document.

Refresh this Document
Go to the Docket